BR9509251A - Composição farmacêutica processo de reverte reduzir ou inibir a resistência a multidrogas ou de restaurar a sensibilidade de um tumor e artigo manufaturado - Google Patents
Composição farmacêutica processo de reverte reduzir ou inibir a resistência a multidrogas ou de restaurar a sensibilidade de um tumor e artigo manufaturadoInfo
- Publication number
- BR9509251A BR9509251A BR9509251A BR9509251A BR9509251A BR 9509251 A BR9509251 A BR 9509251A BR 9509251 A BR9509251 A BR 9509251A BR 9509251 A BR9509251 A BR 9509251A BR 9509251 A BR9509251 A BR 9509251A
- Authority
- BR
- Brazil
- Prior art keywords
- reversing
- restoring
- tumor
- sensitivity
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31830894A | 1994-10-05 | 1994-10-05 | |
| PCT/US1995/012952 WO1996011007A1 (en) | 1994-10-05 | 1995-10-04 | Parenteral pharmaceutical compositions containing gf120918a |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9509251A true BR9509251A (pt) | 1997-10-21 |
Family
ID=23237614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9509251A BR9509251A (pt) | 1994-10-05 | 1995-10-04 | Composição farmacêutica processo de reverte reduzir ou inibir a resistência a multidrogas ou de restaurar a sensibilidade de um tumor e artigo manufaturado |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0784474A2 (pt) |
| JP (1) | JPH10507177A (pt) |
| KR (1) | KR970705997A (pt) |
| AU (1) | AU702519B2 (pt) |
| BR (1) | BR9509251A (pt) |
| CA (1) | CA2201628A1 (pt) |
| CZ (1) | CZ104197A3 (pt) |
| HU (1) | HUT77883A (pt) |
| NZ (1) | NZ295546A (pt) |
| PL (1) | PL319511A1 (pt) |
| RU (1) | RU2157687C2 (pt) |
| WO (1) | WO1996011007A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9710612D0 (en) * | 1997-05-23 | 1997-07-16 | Glaxo Group Ltd | Synthesis of acridine derivatives |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| US5922754A (en) * | 1998-10-02 | 1999-07-13 | Abbott Laboratories | Pharmaceutical compositions containing paclitaxel |
| DE69929704T2 (de) | 1998-10-08 | 2006-07-20 | Smithkline Beecham Plc, Brentford | Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) |
| AT408186B (de) * | 1998-12-15 | 2001-09-25 | Sanochemia Pharmazeutika Ag | Wässerige zubereitung von beta-carotin |
| EP1749540B1 (en) | 1999-05-17 | 2010-10-13 | Cancer Research Ventures Limited | Compositions for improving bioavailability of orally administered drugs |
| US6521635B1 (en) | 2000-01-20 | 2003-02-18 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of MXR transport by acridine derivatives |
| MXPA02012817A (es) * | 2000-06-30 | 2004-07-30 | Inex Pharmaceuticals Inc | Drogas antineoplasicas liposomales y uso de las mismas. |
| WO2003002150A1 (en) * | 2001-06-28 | 2003-01-09 | Wyeth | Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma |
| KR100866728B1 (ko) * | 2004-11-12 | 2008-11-03 | 주식회사종근당 | 타크로리무스를 함유하는 주사제 |
| FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992012132A1 (en) * | 1991-01-11 | 1992-07-23 | Laboratoires Glaxo S.A. | Acridine derivatives |
-
1995
- 1995-10-04 WO PCT/US1995/012952 patent/WO1996011007A1/en not_active Application Discontinuation
- 1995-10-04 RU RU97107466/14A patent/RU2157687C2/ru active
- 1995-10-04 CZ CZ971041A patent/CZ104197A3/cs unknown
- 1995-10-04 CA CA002201628A patent/CA2201628A1/en not_active Abandoned
- 1995-10-04 HU HU9702291A patent/HUT77883A/hu unknown
- 1995-10-04 EP EP95938184A patent/EP0784474A2/en not_active Ceased
- 1995-10-04 JP JP8512678A patent/JPH10507177A/ja active Pending
- 1995-10-04 PL PL95319511A patent/PL319511A1/xx unknown
- 1995-10-04 NZ NZ295546A patent/NZ295546A/xx unknown
- 1995-10-04 BR BR9509251A patent/BR9509251A/pt not_active Application Discontinuation
- 1995-10-04 AU AU38913/95A patent/AU702519B2/en not_active Ceased
- 1995-10-04 KR KR1019970702223A patent/KR970705997A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ104197A3 (en) | 1997-09-17 |
| HUT77883A (hu) | 1998-09-28 |
| JPH10507177A (ja) | 1998-07-14 |
| WO1996011007A1 (en) | 1996-04-18 |
| NZ295546A (en) | 1999-01-28 |
| AU3891395A (en) | 1996-05-02 |
| RU2157687C2 (ru) | 2000-10-20 |
| KR970705997A (ko) | 1997-11-03 |
| MX9702473A (es) | 1997-07-31 |
| EP0784474A2 (en) | 1997-07-23 |
| CA2201628A1 (en) | 1996-04-18 |
| PL319511A1 (en) | 1997-08-18 |
| AU702519B2 (en) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI942993A (fi) | Organoaluminoksituote ja sen käyttö | |
| BR9406028A (pt) | Composição e processo de limpeza | |
| PT978276E (pt) | Comprimidos com revestimento de polimero que compreendem amoxicilina e clavulanato | |
| BR9404114A (pt) | Composição farmacêutica e seu processo de preparação | |
| BR9306917A (pt) | Artigo abrasivo revestido e processo de fabricação do mesmo | |
| BR9300289A (pt) | Composicao de revestimento e artigo | |
| BR9301898A (pt) | Composicao de revestimento e artigo revestido | |
| BR9600300A (pt) | Artigo e composição aquosa | |
| BR9509251A (pt) | Composição farmacêutica processo de reverte reduzir ou inibir a resistência a multidrogas ou de restaurar a sensibilidade de um tumor e artigo manufaturado | |
| BR9406348A (pt) | Composiçao e processo para detetar um ligante e a presença ou quantidade do mesmo | |
| DE69410298D1 (de) | Überzugszusammensetzung und Anwuchsverhindernde Überzugszusammensetzung | |
| BR9300291A (pt) | Composicao de revestimento e artigo | |
| FI103585B (fi) | Rakenneosa ja sen valmistusmenetelmä | |
| BR9605959A (pt) | Composiçao curável substrato e artigo de manufatura | |
| DE59607354D1 (de) | Bearbeitungs-Werkzeug zur Bearbeitung von Lagen-Material od. dgl. | |
| PT915662E (pt) | Produtos revestidos com acucar e processo para a preparacao dos mesmos | |
| DE69409030D1 (de) | Antistatische Beschichtungszusammensetzungen und daraus hergestellte antistatische Schichten | |
| FI943804A (fi) | Suojakerrosrakenne sekä tuote sen valmistamiseksi | |
| BR9306286A (pt) | Artigos e materiais poliméricos | |
| DE69318963D1 (de) | Drehratensensor und dessen Herstellungverfahren | |
| BR9600346A (pt) | Artigo de escrita ou de coloração | |
| BR9404268A (pt) | Material pigmentar | |
| BR9606455A (pt) | Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário | |
| BR9103853A (pt) | Revestimento ou pedra de revestimento | |
| NO306672B1 (no) | N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB34 | Technical and formal requirements: requirement - article 34 of industrial property law | ||
| FA14 | Dismissal: dismissal - article 34 of industrial property law | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |